Breakthrough COVID-19 vaccine has Knoxville ties

in Health & Wellness

KNOXVILLE, Tenn. — “It is a great day for science. It is a great day for humanity,” Pfizer Chairman and CEO Dr. Albert Bourla said Monday morning.

His company had just announced its COVID-19 vaccine had shown more than 90 percent effectiveness in a clinical trial check-in.

And it began, in part, here at the University of Tennessee Medical Center with a shot 200 people, including our own Robin Wilhoit, received.

The 90 percent threshold blew past scientist’s expectations, Dr. Bill Smith with the Volunteer Research Group said.

“A threshold of 75 percent would’ve been good enough to start discussions with the FDA so the fact that this was over 90 percent is really exciting,” Smith said.

Continue Reading on WBIR


Latest from Health & Wellness

Go to Top
Skip to content